Functional oligomerization of purified human papillomavirus types 16 and 6b E7 proteins expressed in Escherichia coli

References

1. Armstrong D. J., Roman A. 1992; Mutagenesis of human papillomavirus types 6 and 16 E7 open reading frames alters the electrophoretic mobility of the expressed proteins. Journal of General Virology 73:1275–1279
   [Google Scholar]
2. Campo M. S., Jarrett W. F. H. 1987; Papillomaviruses and disease. In Molecular Basis of Virus Disease pp 215–243 Russell W. C., Almond J. W. Edited by Cambridge: Cambridge University Press;
   [Google Scholar]
3. Chinami M., Yuge K., Kawano K., Shingu M. 1991; Refolding and purification of human papillomavirus type 16 E7-lacZ protein expressed in E. coli. Protein Purification and Expression 2:175–178
   [Google Scholar]
4. Cunningham B. C., Mulkerrin M. G., Well J. A. 1991; Dimerization of human growth hormone by zinc. Science 253:545–548
   [Google Scholar]
5. De Villiers E. -M. 1989; Heterogeneity of the human papillomavirus group. Journal of Virology 63:4898–4903
   [Google Scholar]
6. De Villiers E. -M., Gissmann L., Zur Hausen H. 1981; Molecular cloning of viral DNA from human genital tracts. Journal of Virology 40:932–935
   [Google Scholar]
7. Dimaio D. 1991; Transforming activity of bovine and human papillomaviruses in cultured cells. Advances in Cancer Research 56:133–159
   [Google Scholar]
8. Dyson N., Howley P. M., Munger K., Harlow E. 1989; The human papillomavirus 16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 243:934–937
   [Google Scholar]
9. Frankel A. D., Chen L., Pabo C. O. 1988; Tat protein from human immunodeficiency virus forms a metal-linked dimer. Science 240:70–73
   [Google Scholar]
10. Gage J. R., Myers C., Wettstein F. O. 1990; The E7 proteins of nononcogenic human papillomavirus type 6b (HPV 6b) and of the oncogenic HPV 16 differ in retinoblastoma protein binding and other properties. Journal of Virology 64:723–730
    [Google Scholar]
11. Heck D. V., Yee C. L., Howley P. M., Munger K. 1992; Efficiency of binding of the retinoblastoma protein correlates with the transforming capacity of the E7 proteins of the human papillomaviruses. Proceedings of the National Academy of Sciences U.S.A: 894442–4446
    [Google Scholar]
12. Huang P. S., Patric D. R., Edwards G., Goodhart P. J., Huber H. E., Miles L., Garsky V. M., Oliff A., Heimbrook D. C. 1993; Protein domain governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Molecular and Cellular Biology 13:953–960
    [Google Scholar]
13. Imai Y., Matsushima Y., Sugimura T., Terada M. 1991; Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the under- phosphorylated form of the retinoblastoma gene product. Journal of Virology 65:4966–4972
    [Google Scholar]
14. Kaelin W. G., Krek W., Sellers W. R., Decaprio J. A., Ajchen-Baum F., Fuchs C. S., Chittenden T., Li Y., Farnham P. J., Blanar M. A., Livingston D. M., Flemington E. K. 1992; Expression and cloning of a cDNA encoding a retinoblastomabinding protein with E2F-like properties. Cell 70:351–364
    [Google Scholar]
15. Mcintyre M. C., Frattini M. G., Grossman S. R., Laimins L. A. 1993; Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. Journal of Virology 67:3142–3150
    [Google Scholar]
16. Munger K., Werness B. A., Dyson N., Phelps W. C., Harlow E., Howley P. M. 1989; Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO Journal 8:4099–1105
    [Google Scholar]
17. Okada C. Y., Rechsteiner M. 1982; Introduction of macromolecules into cultured mammalian cells by osmotic lysis of picnocytic vesicles. Cell 29:33–41
    [Google Scholar]
18. Patric D. R., Zhang K., Defeo-Jones D., Vuocolo G. R., Maigetter R. Z., Sardana M. K., Oliff A., Heimbrook D. C. 1992; Characterization of functional HPV-16 E7 protein produced in Escherichia coli. Journal of Biological Chemistry 267:6910–6915
    [Google Scholar]
19. Sato H., Watanabe S., Furuno A., Yoshiike K. 1989; Human papillomavirus type 16 E7 protein expressed in Escherichia coli and monkey COS-1 cells: immunofluorescence detection of the nuclear E7 protein. Virology 170:311–315
    [Google Scholar]
20. Schwartz E., Dürst M., Demankowski C., Lattermann O., Zech R., Wolfsperger E., Suhai S., Zurhausen H. 1983; DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO Journal 2:2341–2348
    [Google Scholar]
21. Smotkin D., Wettstein F. O. 1987; The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. Journal of Virology 61:1686–1689
    [Google Scholar]
22. Studier F. M., Moffatt R. J. 1986; Use of T7 RNA polymerase to direct selective expression of cloned genes. Journal of Molecular Biology 189:113–130
    [Google Scholar]
23. Tindle R. W., Smith J. A., Geysen H. M., Selvey L. A., Frazer I. H. 1990; Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. Journal of General Virology 71:1347–1354
    [Google Scholar]
24. Yasumoto S., Burkhardt A. L., Doniger J., Dipaolo J. A. 1986; Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells. Journal of Virology 57:572–577
    [Google Scholar]
25. Yee C., Krishnan-Hewlett I., Baker C. C., Schlegel R., Howley P. M. 1985; Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. American Journal of Pathology 119:361–366
    [Google Scholar]
26. Zurhausen H. 1983; Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events. Lancet ii:1370–1372
    [Google Scholar]